No Data
Returns On Capital Are Showing Encouraging Signs At Tactile Systems Technology (NASDAQ:TCMD)
Tactile Systems Technology's Nimbl Gets Medicare Approval
Express News | Tactile Medical Receives Pdac Approval for Nimbl™ Lymphedema Platform
Tactile Medical Receives PDAC Approval for Nimbl Lymphedema Platform
BTIG Maintains Tactile Systems Technology(TCMD.US) With Buy Rating, Maintains Target Price $16
BTIG analyst Ryan Zimmerman maintains $Tactile Systems Technology(TCMD.US)$ with a buy rating, and maintains the target price at $16.According to TipRanks data, the analyst has a success rate of 48.7%
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), BioMarin Pharmaceutical (BMRN) and Tactile Systems Technology (TCMD)